Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 2.00 (4.65%)
Spread: 2.00 (4.545%)
Open: 43.75
High: 45.00
Low: 43.45
Prev. Close: 43.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Mon, 11th May 2020 12:03

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Open Orphan PLC - pharmaceutical services - Subsidiary hVIVO enters contract with Nasdaq-listed diagnostics firm Quotient to use MosaiQ system and MosaiQ Covid-19 antibody microarray to screen for SARS-CoV-2 antibodies, which is produced when humans are infected with Covid-19.

----------

Avacta Group PLC - biotherapeutics - To ship Affimer reagents for the development of a point-of-care saliva-based Covid-19 antigen test strip by Cytiva, for CE Marking in Europe and US Food & Drug Administration approval. Will also be sent to Adeptrix, which is developing Covid-19 laboratory test to run on hospital mass spectrometers.

----------

BlueRock Diamonds PLC - diamonds - Recommences operations at Kareevlei diamond mine in Kimberley, South Africa. Expects to start operations at full capacity by the end of May, but expansion plans on hold.

----------

Chesterfield Resources PLC - mineral exploration - Plans to resume drilling operations on its Troodos West licences by mid-June, following government of Cyprus providing a detailed four-phase roadmap out of lockdown, which is spread over the next two months up until July 14.

----------

Blencowe Resources PLC - mining - Recommences key metallurgical test work on Orom-Cross graphite project in Uganda, after being on hold for six weeks since late March due to lockdown. Due to restart 59-hole diamond drilling programme, which is designed to deliver a maiden JORC resource during the middle of 2020.

----------

Phoenix Spree Deutschland Ltd - real estate - Rent collection for April at 98% compared to 99% in January. Refinances EUR16.4 million in debt acquired as part of acquisition of Brandenburg apartment complex. Will pay second dividend of 5.15 cents per share, remain confident in long-term outlook.

----------

Petro Matad Ltd - Mongolian oil explorer - Executive directors, non-executive directors and senior managers to take salary cut averaging 50%, backdated to the start of second quarter of 2020. Professional advisers to reduce its fees by up to 45%. To focus on securing Block XX exploitation licence and retaining its Block V exploitation licence.

----------

Anglo African Agriculture PLC - agriculture investment - Trading subsidiary Dynamic Intertrade remains fully operational despite South Africa lockdown, due to providing essential services as a food manufacturer. Expects revenue for six months ending October 31 to double year-on-year. Progress with Comarco transaction protracted due to general market environment.

----------

iEnergizer Ltd - media and technology services - Continues to trade effectively in lockdown imposed by government of India. Business operating at 80% to 90% efficiency to its clients. Balance sheet, net cash position and long-term customer relationships remain strong.

----------

Cake Box Holdings PLC - cakes retailer - Following initial trial of limited number of stores operating Click & Collect service and delivery in partnership, now has 79 franchise stores open, offering a limited menu of products. Expects to have full high street estate open by early June.

----------

Midwich Group PLC - audio-visual distributor - Delivered strong performance in 2019, with growth in revenue and rise in profit. Challenging trading conditions over the past two months, expected to continue until lockdown conditions in Europe and North America are "significantly eased".

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Jun 2020 09:30

Avacta's Covid-19 test reaches prototype stage

(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.

Read more
4 Jun 2020 14:31

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Read more
4 Jun 2020 09:27

Avacta raising £45m to fund diagnostics and therapies pipeline

(Sharecast News) - Biotherapeutic and reagent developer Avacta Group announced its intention to raise up to £45m through a placing to institutional and other investors, a direct subscription with the company, and offers to retail and other investors via the PrimaryBid platform, it announced on Thursday.

Read more
20 May 2020 10:16

Avacta signs Covid-19 test distribution deal with Boohoo founders

(Sharecast News) - Avacta Group has entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based rapid test for the Covid-19 antigen, it announced on Wednesday.

Read more
11 May 2020 08:43

Avacta Group ships Covid-19 testing reagents

(Sharecast News) - Biotherapeutics developer Avacta Group shipped out reagents for Covid-19 antigen testing to its diagnostic test development partners on Monday.

Read more
6 May 2020 17:18

Avacta Group Reports Widened Loss Amid Higher Operating Expenses

Avacta Group Reports Widened Loss Amid Higher Operating Expenses

Read more
1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Read more
1 May 2020 13:17

Avacta to collaborate with Adeptrix on Covid-19 tests

(Sharecast News) - Biotherapeutics developer Avacta has entered into a collaboration agreement with American firm Adeptrix to develop a high throughput Covid-19 antigen test using its proprietary bead-assisted mass spectrometry (BAMS) platform.

Read more
29 Apr 2020 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

Read more
22 Apr 2020 14:50

Avacta shares surge on progress with Covid test

(Sharecast News) - Avacta Group said on Wednesday that, in four weeks and "well ahead" of schedule, it had successfully generated multiple 'Affimer' reagents that bound the SARS-COV-2 viral antigen as part of the collaboration with Cytiva - formerly GE Healthcare Life Sciences - to develop an Affimer-based rapid test for the Covid-19 coronavirus infection.

Read more
14 Apr 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
8 Apr 2020 10:41

Avacta To Co-Develop Test That Can Diagnose Covid-19 In Minutes

Avacta To Co-Develop Test That Can Diagnose Covid-19 In Minutes

Read more
7 Apr 2020 07:31

Avacta Raises More-Than-Expected GBP3.8 Million In Share Placing

Avacta Raises More-Than-Expected GBP3.8 Million In Share Placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.